Aerotek’s clients gain increased access to qualified candidates for their positions with the company's acquisition of Kforce’ scientific division.
Aerotek Scientific® LLC, a subsidiary of Aerotek, Inc., is excited to announce the acquisition of the scientific division of Kforce. Aerotek (www.aerotek.com) is a leading provider of technical, professional and industrial recruiting and staffing. Financial details of the acquisition have not been disclosed by company officials.
Aerotek acquired the employees, clients, contractors, and relevant data of the scientific division of Kforce. Staff previously employed by the scientific division of Kforce will continue to service their clients and contractors while working for Aerotek Scientific.
Aerotek Scientific places candidates of all levels at a variety of companies in many industries including: pharmaceuticals, biotechnology, healthcare, food & beverage, clinical research, chemical and plastics. The scientific division of Kforce’s similar focus on these markets complements Aerotek’s existing structure and will expand the company throughout the scientific industry. Kforce will retain the recruitment services that apply to the clinical trials industry.
“The acquisition of the scientific division of Kforce strengthens the presence of Aerotek Scientific within niche scientific industries nationwide,” said Thomas M. Thornton, president and chief executive officer of Aerotek. In addition to the internal growth from which our company will benefit, former Kforce Scientific and existing Aerotek clients now have access to a larger pool of qualified candidates for their positions, and contract employees have significantly more jobs available to them through our services.”
As technologies evolve and new career specialties emerge, the market for scientific professionals has continued to increase. The demand for qualified, experienced talent in scientific industries has become progressively competitive. The acquisition of the scientific division of Kforce bolsters Aerotek’s collective expertise and reinforces the company’s position as a leader in this marketplace.
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.